BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34101529)

  • 21. CD8
    Masterson L; Lechner M; Loewenbein S; Mohammed H; Davies-Husband C; Fenton T; Sudhoff H; Jani P; Goon P; Sterling J
    Eur J Cancer; 2016 Nov; 67():141-151. PubMed ID: 27669501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma.
    Larsson GL; Helenius G; Andersson S; Sorbe B; Karlsson MG
    Gynecol Oncol; 2013 May; 129(2):406-11. PubMed ID: 23402906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human papillomavirus and survival of patients with oropharyngeal cancer.
    Ang KK; Harris J; Wheeler R; Weber R; Rosenthal DI; Nguyen-Tân PF; Westra WH; Chung CH; Jordan RC; Lu C; Kim H; Axelrod R; Silverman CC; Redmond KP; Gillison ML
    N Engl J Med; 2010 Jul; 363(1):24-35. PubMed ID: 20530316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary surgery results in no survival benefit compared to primary radiation for oropharyngeal cancer patients stratified by high-risk human papilloma virus status.
    Lybak S; Ljøkjel B; Haave H; Karlsdottir À; Vintermyr OK; Aarstad HJ
    Eur Arch Otorhinolaryngol; 2017 Jan; 274(1):477-487. PubMed ID: 27491318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HPV-Positive Oropharyngeal Carcinoma: A Systematic Review of Treatment and Prognosis.
    Wang MB; Liu IY; Gornbein JA; Nguyen CT
    Otolaryngol Head Neck Surg; 2015 Nov; 153(5):758-69. PubMed ID: 26124261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oropharyngeal cancers: significance of HPV16 detection in neck lymph nodes.
    Mirghani H; Ferchiou M; Moreau F; Vourexakis Z; Amen F; Breuskin I; Lefèvre M; Casiraghi O; Drusch F; Soussan P; Vielh P; St Guily JL
    J Clin Virol; 2013 Jun; 57(2):120-4. PubMed ID: 23478163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen receptor α as a predictive biomarker for survival in human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Kwon S; Ahn SH; Jeong WJ; Jung YH; Bae YJ; Paik JH; Chung JH; Kim H
    J Transl Med; 2020 Jun; 18(1):240. PubMed ID: 32546279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep Learning Predicts HPV Association in Oropharyngeal Squamous Cell Carcinomas and Identifies Patients with a Favorable Prognosis Using Regular H&E Stains.
    Klein S; Quaas A; Quantius J; Löser H; Meinel J; Peifer M; Wagner S; Gattenlöhner S; Wittekindt C; von Knebel Doeberitz M; Prigge ES; Langer C; Noh KW; Maltseva M; Reinhardt HC; Büttner R; Klussmann JP; Wuerdemann N
    Clin Cancer Res; 2021 Feb; 27(4):1131-1138. PubMed ID: 33262137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus and oropharyngeal squamous cell carcinoma: a New Zealand cohort study.
    Ou P; Gear K; Rahnama F; Thomas S; Nagappan R; Kee D; Waldvogel-Thurlow S; Jain R; McIvor N; Izzard M; Douglas R
    ANZ J Surg; 2018 Apr; 88(4):E278-E283. PubMed ID: 27647686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The current epidemic of HPV-associated oropharyngeal cancer: An 18-year Danish population-based study with 2,169 patients.
    Zamani M; Grønhøj C; Jensen DH; Carlander AF; Agander T; Kiss K; Olsen C; Baandrup L; Nielsen FC; Andersen E; Friborg J; von Buchwald C
    Eur J Cancer; 2020 Jul; 134():52-59. PubMed ID: 32460181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV-16 infection predicts treatment outcome in oropharyngeal squamous cell carcinoma.
    Nichols AC; Faquin WC; Westra WH; Mroz EA; Begum S; Clark JR; Rocco JW
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):228-34. PubMed ID: 19201294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
    van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
    Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review on location and timing of distant progression in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
    Tiedemann D; Jakobsen KK; von Buchwald C; Grønhøj C
    Head Neck; 2019 Mar; 41(3):793-798. PubMed ID: 30582231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mate pair sequencing of oropharyngeal squamous cell carcinomas reveals that HPV integration occurs much less frequently than in cervical cancer.
    Gao G; Johnson SH; Kasperbauer JL; Eckloff BW; Tombers NM; Vasmatzis G; Smith DI
    J Clin Virol; 2014 Mar; 59(3):195-200. PubMed ID: 24440282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does HPV type affect outcome in oropharyngeal cancer?
    Nichols AC; Dhaliwal SS; Palma DA; Basmaji J; Chapeskie C; Dowthwaite S; Franklin JH; Fung K; Kwan K; Wehrli B; Howlett C; Siddiqui I; Salvadori MI; Winquist E; Ernst S; Kuruvilla S; Read N; Venkatesan V; Todorovic B; Hammond JA; Koropatnick J; Mymryk JS; Yoo J; Barrett JW
    J Otolaryngol Head Neck Surg; 2013 Feb; 42(1):9. PubMed ID: 23663293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer.
    Liu SZ; Zandberg DP; Schumaker LM; Papadimitriou JC; Cullen KJ
    Oral Oncol; 2015 Sep; 51(9):862-9. PubMed ID: 26183400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of HPV16-positive oropharyngeal cancer in Black patients over time: University of Maryland 1992-2007.
    Zandberg DP; Liu S; Goloubeva OG; Schumaker LM; Cullen KJ
    Cancer Prev Res (Phila); 2015 Jan; 8(1):12-9. PubMed ID: 24916537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.